113 related articles for article (PubMed ID: 29534590)
1. Clinically node-positive bladder cancer: oncological results of induction chemotherapy and consolidative surgery.
Stanik M; Poprach A; Macik D; Capak I; Maluskova D; Mareckova N; Lakomy R; Jarkovsky J; Dolezel J
Neoplasma; 2018; 65(2):287-291. PubMed ID: 29534590
[TBL] [Abstract][Full Text] [Related]
2. A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy.
Zargar-Shoshtari K; Zargar H; Lotan Y; Shah JB; van Rhijn BW; Daneshmand S; Spiess PE; Black PC
J Urol; 2016 Jan; 195(1):53-9. PubMed ID: 26205531
[TBL] [Abstract][Full Text] [Related]
3. Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
Hermans TJ; Fransen van de Putte EE; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; de Wit R; Beerepoot LV; Verhoeven RH; van Rhijn BW
Eur J Cancer; 2016 Dec; 69():1-8. PubMed ID: 27814469
[TBL] [Abstract][Full Text] [Related]
4. Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer.
Pak S; You D; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Kim CS; Ahn H
Clin Genitourin Cancer; 2019 Jun; 17(3):e420-e428. PubMed ID: 30713014
[TBL] [Abstract][Full Text] [Related]
5. Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients.
Kijima T; Tanaka H; Koga F; Masuda H; Yoshida S; Yokoyama M; Ishioka J; Matsuoka Y; Saito K; Kihara K; Fujii Y
BJU Int; 2019 Aug; 124(2):242-250. PubMed ID: 30811784
[TBL] [Abstract][Full Text] [Related]
6. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
Koga F; Kihara K; Yoshida S; Yokoyama M; Saito K; Masuda H; Fujii Y; Kawakami S
BJU Int; 2012 Mar; 109(6):860-6. PubMed ID: 21854531
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
8. Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience.
Ho PL; Willis DL; Patil J; Xiao L; Williams SB; Melquist JJ; Tart K; Parikh S; Shah JB; Delacroix SE; Navai N; Siefker-Radtke A; Dinney CP; Pisters LL; Kamat AM
Urol Oncol; 2016 Feb; 34(2):59.e1-8. PubMed ID: 26421586
[TBL] [Abstract][Full Text] [Related]
9. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
10. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
[TBL] [Abstract][Full Text] [Related]
11. Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery.
Urakami S; Yuasa T; Yamamoto S; Sakura M; Tanaka H; Hayashi T; Uehara S; Inoue Y; Fujii Y; Masuda H; Fukui I; Yonese J
Int J Clin Oncol; 2015 Dec; 20(6):1171-8. PubMed ID: 25953680
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
Stein JP; Cai J; Groshen S; Skinner DG
J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder Cancer.
von Deimling M; Mertens LS; van Rhijn BWG; Lotan Y; Spiess PE; Daneshmand S; Black PC; Pallauf M; D'Andrea D; Moschini M; Soria F; Del Giudice F; Afferi L; Laukhtina E; Yanagisawa T; Kawada T; Teoh JY; Abufaraj M; Ploussard G; RoumiguiƩ M; Karakiewicz PI; Babjuk M; Gontero P; Xylinas E; Rink M; Shariat SF; Pradere B
Eur Urol Open Sci; 2023 May; 51():39-46. PubMed ID: 37187719
[TBL] [Abstract][Full Text] [Related]
14. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.
Moschini M; Morlacco A; Briganti A; Hu B; Colombo R; Montorsi F; Frank I; Daneshmand S; Karnes RJ
Eur Urol Focus; 2018 Mar; 4(2):245-251. PubMed ID: 28753820
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Treatment Strategies for Bladder Cancer With Clinical Evidence of Regional Lymph Node Involvement.
Galsky MD; Stensland K; Sfakianos JP; Mehrazin R; Diefenbach M; Mohamed N; Tsao CK; Boffetta P; Wiklund P; Oh WK; Mazumdar M; Ferket B
J Clin Oncol; 2016 Aug; 34(22):2627-35. PubMed ID: 27269939
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy followed by surgery in node positive bladder cancer.
Meijer RP; Mertens LS; van Rhijn BW; Bex A; van der Poel HG; Meinhardt W; Kerst JM; Bergman AM; Fioole-Bruining A; van Werkhoven E; Horenblas S
Urology; 2014 Jan; 83(1):134-9. PubMed ID: 24246329
[TBL] [Abstract][Full Text] [Related]
17. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
[TBL] [Abstract][Full Text] [Related]
18. Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review.
Koga F; Kihara K
Int J Urol; 2012 May; 19(5):388-401. PubMed ID: 22409269
[TBL] [Abstract][Full Text] [Related]
19. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]